纳米疫苗结合了定制的本地抗PD-L1仓库,用于增强瘤免疫治疗

相关实验视频

Updated: Jul 26, 2025

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

Qian Chen¹, Mengjuan Sun², Yanan Li³

¹State Key Laboratory of Natural Medicines, China Pharmaceutical University, 639 Longmian Avenue, Nanjing 211198, China; Jiangsu Provincial Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China.

Nanomedicine : nanotechnology, biology, and medicine

|June 21, 2023

概括

这项研究将纳米疫苗与抗PD-L1疗法结合起来,以改善癌症治疗. 新型组合免疫疗法通过激活免疫反应,增强了抗瘤疗效和延长了生存期.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
生物技术是生物技术.

背景情况:

免疫检查点封锁 (ICB) 的低响应率限制了其临床使用.
治疗性癌症疫苗可以通过免疫调节来增强ICB的疗效.
开发组合策略对于改善抗瘤免疫力至关重要.

研究的目的:

开发一种使用纳米疫苗和抗PD-L1疗法的组合免疫疗法.
评估组合治疗的抗瘤疗效和免疫反应.
为了研究这种策略在黑色素瘤治疗中的潜力.

主要方法:

制造的纳米疫苗 (LCLs) 来自整个瘤细胞溶解物和CpG脂质体.
使用大豆脂胆和甘油二醇酸盐制备的抗PD-L1载脂凝 (aPD-L1@LG).
在黑色素瘤模型中,通过皮下和aPD-L1@LG内注射LCLs.

主要成果:

皮下LCL的使用激活了树突细胞 (DCs).
内瘤aPD-L1@LG确保了持续的免疫检查点阻塞活动.
组合免疫疗法显示出增强的抗瘤疗效和延长的生存时间.

结论:

开发的组合免疫疗法有效地激活了全身抗瘤免疫反应.
这种理性的设计显示了作为一种新的黑色素瘤治疗策略的希望.
组合免疫疗法提供了一种潜在的方法来克服ICB耐药性.

关键词:

组合免疫疗法是一种联合免疫疗法.免疫检查站封锁免疫检查站封锁脂质凝是一种脂质凝.纳米疫苗的使用方法

更多相关视频

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...